The DOI matches its OpenAlex record.
Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma.
Abstract
Antigen challenge of passively sensitized chopped human lung resulted in the generation of several arachidonic acid cyclooxygenase metabolites (AACM): thromboxane A2 (TxA2) as measured by its stable metabolite TxB2, prostaglandin D2 (PgD2), prostacyclin (PgI2) as measured by its stable metabolite 6-keto-PgF1 alpha, prostaglandin F2 alpha (PgF2 alpha), and prostaglandin E (PgE). The kinetics of AACM release after antigen challenge paralleled histamine release. All AACM were released in an antigen dose-dependent manner and reached maximal release at antigen concentrations lower than those required for maximal histamine release. Quantitatively, of the AACM measured, PgD2 and PgI2 were found to predominate in anaphylactic reactions of human lung parenchyma. Generation of PgD2 and PgI2 were 3- to 7-fold greater than that of other AACM measured. Thromboxane B2 was generated in quantities comparable to PgE and PgF2 alpha. Studies were designed to test the hypothesis that lung smooth muscle contraction per se can account for the generated AACM that are released during anaphylaxis of the lung. The studies compared antigen-induced AACM generation with methacholine-induced (10(-4) M) AACM generation. The failure to confirm this hypothesis was especially evident for PgD2 where release was dependent on mast cell activation. Thromboxane A2, PgD2, and PgI2 have been reported to have potent effects on smooth muscle. Our data suggested that these AACM are generated in such sufficient quantities that they may function in important aspects of the modulation of hypersensitivity responses in human lungs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Galli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Pettipher, R., Hansel, T. T., & Armer, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2266 · Cited by 317
Kinins are generated during experimental rhinovirus colds
Naclerio, R. M., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A., Hendley, J. O., Sorrentino, J., & Gwaltney, J. M. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.1.133 · Cited by 282
Togias, A. G., Naclerio, R. M., Proud, D., Fish, J. E., Adkinson, N. F., Kagey-Sobotka, A., Norman, P. S., & Lichtenstein, L. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112113 · Cited by 261
Self-citationIbuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron.
Kennedy, T. P., Rao, N. V., Noah, W., Michael, J. R., Jafri, M. H., Gurtner, G. H., & Hoidal, J. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114876 · Cited by 72
Metadata
- Authors
- Schulman, E. S., Newball, H. H., Demers, L. M., Fitzpatrick, F. A., & Adkinson, N. F.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 1981-10-01
- Volume
- 124
- Issue
- 4
- Pages
- 402-6
- OpenAlex
- W2181620901
- Cited by
- 163
- References
- 0
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. https://app.cochat.ai/papers/10.1164/arrd.1981.124.4.402
- The paper
- Schulman, E. S., Newball, H. H., Demers, L. M., Fitzpatrick, F. A., & Adkinson, N. F. (1981). Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. PubMed. https://doi.org/10.1164/arrd.1981.124.4.402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.